{"id":36032,"date":"2026-01-15T10:30:16","date_gmt":"2026-01-15T10:30:16","guid":{"rendered":"https:\/\/library.mirrorsmed.org\/?page_id=36032"},"modified":"2026-02-10T14:22:37","modified_gmt":"2026-02-10T14:22:37","slug":"spotlight-2025","status":"publish","type":"page","link":"https:\/\/library.mirrorsmed.org\/index.php\/spotlight-2025\/","title":{"rendered":"Spotlight 2025"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Page Title Section&#8221; _builder_version=&#8221;4.22.1&#8243; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_direction=&#8221;170deg&#8221; background_color_gradient_stops=&#8221;#006871 0%|rgba(0,0,0,0) 76%&#8221; background_color_gradient_overlays_image=&#8221;on&#8221; background_color_gradient_start=&#8221;#006871&#8243; background_color_gradient_end=&#8221;rgba(0,0,0,0)&#8221; background_color_gradient_end_position=&#8221;76%&#8221; background_image=&#8221;https:\/\/library.mirrorsmed.org\/wp-content\/uploads\/2023\/09\/MiMe_Library_header-002-300&#215;36.png&#8221; custom_margin=&#8221;-70px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.22.1&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text admin_label=&#8221;Title&#8221; _builder_version=&#8221;4.22.1&#8243; text_font=&#8221;||||||||&#8221; header_font=&#8221;Poppins|600|||||||&#8221; header_font_size=&#8221;56px&#8221; header_line_height=&#8221;1.2em&#8221; header_2_font=&#8221;||||||||&#8221; header_2_font_size=&#8221;60px&#8221; background_layout=&#8221;dark&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;||-1px|||&#8221; custom_padding=&#8221;||0px|||&#8221; animation_style=&#8221;fade&#8221; header_font_size_tablet=&#8221;&#8221; header_font_size_phone=&#8221;40px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1 style=\"text-align: center;\">Mirrors of Medicine library<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.22.1&#8243; background_color=&#8221;rgba(0,104,113,0.42)&#8221; custom_padding=&#8221;9px||90px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;2&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.22.1&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_button button_url=&#8221;https:\/\/library.mirrorsmed.org\/&#8221; button_text=&#8221;Log in to watch and download RENALC, BLADDR &#038; PROSCA 2025 presentations&#8221; button_alignment=&#8221;center&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;26px&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;#006871&#8243; button_border_width=&#8221;0px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][et_pb_text disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.22.1&#8243; text_text_color=&#8221;#ffffff&#8221; text_font_size=&#8221;18px&#8221; header_font_size=&#8221;45px&#8221; background_layout=&#8221;dark&#8221; custom_padding=&#8221;50px||||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1 style=\"text-align: center;\"><span style=\"color: #008080;\"><strong>In the spotlight<\/strong><\/span><\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;|auto|-14px|auto||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(140,12,52,0.5)&#8221; width=&#8221;100%&#8221; min_height=&#8221;158px&#8221; custom_margin=&#8221;2px||39px|1px|false|false&#8221; custom_padding=&#8221;37px|10px|50px|10px|false|false&#8221; hover_enabled=&#8221;0&#8243; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Progression after IO for RCC: What&#8217;s next?<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Presentor: Lisa Pickering<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\"><\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Learning objective: Learn about promising post-IO strategies for RCC progression, including HIF-2\u03b1 inhibitors and novel targets such as LAG3, CAR-T, TIGIT, and PARP, despite limited evidence for IO rechallenge. <\/span><\/pee><!-- [et_pb_line_break_holder] --><\/p>\n<div style=\"height:360px;position:relative;\"><iframe src=\"https:\/\/player.vimeo.com\/video\/1163593832\"<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Progression after IO: What&#8217;s next?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(119,62,108,0.52)&#8221; min_height=&#8221;118px&#8221; custom_margin=&#8221;2px||31px||false|false&#8221; custom_padding=&#8221;33px|10px|7px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>How to approach an mHSPC patient: Insights from clinical practice<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Presentor: Amit Bahl<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\"><\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013> <pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Tailor mHSPC treatment by counseling patients on all treatment options, proactively managing adverse events to optimize outcomes\/quality of life, and leveraging multidisciplinary care.<!-- [et_pb_line_break_holder] --><\/h3>\n<div style=\"height:375px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1163616641?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=1163616641&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->     [\/et_pb_code][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(211,92,94,0.52)&#8221; min_height=&#8221;158px&#8221; custom_margin=&#8221;2px||38px||false|false&#8221; custom_padding=&#8221;27px|10px|4px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Tailoring first-line treatment strategies for advanced bladder cancer: Toward individualised care<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Moderator: G\u00e9raldine Pignot<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\">Presenter: Daniel Raggi<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Learning objective: Acknowledge the first-line standards for advanced\/metastatic bladder cancer, the ongoing relevance of chemotherapy + IO in selected cases, and clinical characteristics and key biomarkers that guide individualised care.<!-- [et_pb_line_break_holder] --><\/h3>\n<div style=\"height:360px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1143505948&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(140,12,52,0.5)&#8221; width=&#8221;100%&#8221; min_height=&#8221;158px&#8221; custom_margin=&#8221;2px||2px|1px|false|false&#8221; custom_padding=&#8221;33px|10px|5px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>RENALC meets BLADDR: When to stop IO?<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Moderator: Ignacio Duran<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\">Panel: Philippe Barth\u00e9l\u00e9my, Raquel Br\u00e1s, Sylvie Rottey, Bernadett Szabados<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Learning objective: Gain insights into real-life bladder and renal cancer cases where discontinuation of immunotherapy may be appropriate, through an interactive case-based panel discussion.<!-- [et_pb_line_break_holder] --><\/span><\/pee><!-- [et_pb_line_break_holder] --><\/p>\n<div style=\"height:350px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1143100010?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; min_height=&#8221;1396.2px&#8221; custom_margin=&#8221;|auto|-73px|auto||&#8221; custom_padding=&#8221;0px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(211,92,94,0.52)&#8221; min_height=&#8221;158px&#8221; custom_margin=&#8221;2px||40px||false|false&#8221; custom_padding=&#8221;27px|10px|20px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Personalised adjuvant immunotherapy in MIBC and the impact of ctDNA testing<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Moderator: Petros Grivas<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\">Presenter: Thomas Powles (remote)<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Learning objective: By reviewing latest congress highlights data, recognise the impact of ctDNA testing, and learn how to tailor adjuvant immunotherapy on a patient-specific level.<!-- [et_pb_line_break_holder] --><\/h3>\n<div style=\"height:360px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1143196576?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(140,12,52,0.5)&#8221; width=&#8221;100%&#8221; min_height=&#8221;158px&#8221; custom_margin=&#8221;2px||2px|1px|false|false&#8221; custom_padding=&#8221;33px|10px|5px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Metastatic pRCC: translating current evidence into clinical decision-making<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\">Moderator: Sylvie Rottey<!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Case presenter: Ignacio Dur\u00e1n<!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Panel: Ignacio Dur\u00e1n, Lisa Pickering, Thomas Powles (virtual)<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Learning objective: Trace papillary RCC evolution from classification to molecular features and treatments. Get up-to-date approaches to treat advanced clinical cases, and catch a glimpse of future therapies.<!-- [et_pb_line_break_holder] --><\/span><\/pee><!-- [et_pb_line_break_holder] --><\/p>\n<div style=\"height:350px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1143057960?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(119,62,108,0.52)&#8221; min_height=&#8221;118px&#8221; custom_margin=&#8221;2px||39px||false|false&#8221; custom_padding=&#8221;33px|10px|0px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Precision strategies in mHSPC: State of the art and future directions<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Moderator: M\u00e1rio Fontes-Sousa<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\">Presenters: Nuno Vau, David Olmos<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013> <pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Review the current treatment approaches in mHSPC and learn how to optimise outcomes. Understand how to integrate genomic profiling to guide emergent therapies in mHSPC.<!-- [et_pb_line_break_holder] --><\/h3>\n<div style=\"height:375px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1143832209?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=1143832209&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->     [\/et_pb_code][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(211,92,94,0.52)&#8221; min_height=&#8221;158px&#8221; custom_margin=&#8221;2px||20px||false|false&#8221; custom_padding=&#8221;27px|10px|4px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>From risk stratification to management: Contemporary strategies for NMIBC<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\">Moderator: F\u00e9lix Guerrero-Ramos<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\">Presenter: Laura Mertens<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>\u00a0 <pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Learning objective: Review low-\/intermediate-\/high-risk NMIBC definitions, learn about BCG failure categories and novel therapeutic approaches post-BCG from key trials.<!-- [et_pb_line_break_holder] --><\/h3>\n<div style=\"height:360px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1143148117?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;35px|||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(119,62,108,0.52)&#8221; min_height=&#8221;118px&#8221; custom_margin=&#8221;2px||20px||false|false&#8221; custom_padding=&#8221;33px|10px|0px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Molecular diagnostics in motion: Liquid biopsies and tissue testing in mCRPC<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\">Moderator: Derya Tilki<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\">Presenter: David Olmos<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013> <pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Learning objective: Understand why targeted therapies require molecular selection and prioritise testing: somatic vs germline, biopsy\/plasma strengths\/limits, basic sequencing principles, and molecular targets.<!-- [et_pb_line_break_holder] --><\/h3>\n<div style=\"height:375px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1144111319?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=1144111319&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script><!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->     [\/et_pb_code][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; disabled_on=&#8221;on|on|on&#8221; module_id=&#8221;mail2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(211,92,94,0.52)&#8221; min_height=&#8221;158px&#8221; custom_margin=&#8221;2px||20px||false|false&#8221; custom_padding=&#8221;27px|10px|4px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Update lecture on first-line treatment for advanced UCa<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\">Moderators: Dora Nieders\u00fc\u00df-Beke<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\">Presenter: Gunhild von Amsberg<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>\u00a0 <pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Gunhild von Amsberg presented at BLADDR 2024 how to individualise the selection of the first-line treatment for advanced UCa based on efficacy, safety, patient characteristics and QoL<!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!\u2013- [et_pb_br_holder] -\u2013><\/span><\/pee><!-- [et_pb_line_break_holder] --><\/h3>\n<div style=\"height:360px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1033938700?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(119,62,108,0.52)&#8221; min_height=&#8221;158px&#8221; custom_margin=&#8221;2px||20px||false|false&#8221; custom_padding=&#8221;27px|10px|4px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Lecture and case discussion on mHSPC<!-- [et_pb_line_break_holder] --><\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\">Case presenter: Daan De Maeseneer<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\">Presenter: Gero Kramer<\/span><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><span style=\"color: #ffffff;\">Panel: Elena Castro, Aurelius Omlin, Fabio Turco, Ursula Vogl<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">A case of a 68-year-old man with mHSPC and comorbidities typical for his age is presented. The audience votes on their preferred treatment option, after which Gero Kramer reviews the latest evidence on managing synchronous mHSPC. The panel discusses how this impacts the clinical case, followed by a re-vote of the audience.<\/span><\/pee><!-- [et_pb_line_break_holder] --><\/h3>\n<div style=\"height:350px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1038864063?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; disabled_on=&#8221;on|on|on&#8221; module_id=&#8221;mail3&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(211,92,94,0.52)&#8221; min_height=&#8221;158px&#8221; custom_margin=&#8221;2px||20px||false|false&#8221; custom_padding=&#8221;27px|10px|4px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Lecture and case discussion: MIBC congress highlights from ESMO<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\">Moderators: Petros Grivas<!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Presenter: Maria De Santis<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>\u00a0 <pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Maria De Santis summarised at BLADDR 2024 the latest data on adjuvant, neoadjuvant and perioperative concepts for MIBC from clinical trials shared at ESMO. She translates this knowledge into clinical practice with a clinical case!<!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><!\u2013- [et_pb_br_holder] -\u2013><!\u2013- [et_pb_br_holder] -\u2013><\/span><\/pee><!-- [et_pb_line_break_holder] --><\/p>\n<div style=\"height:360px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1038490913?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(119,62,108,0.52)&#8221; min_height=&#8221;158px&#8221; custom_margin=&#8221;2px||20px||false|false&#8221; custom_padding=&#8221;27px|10px|4px|10px|false|false&#8221; border_radii=&#8221;on|14px|14px|14px|14px&#8221; border_width_all=&#8221;13px&#8221; border_color_all=&#8221;#8c0c34&#8243; border_style_all=&#8221;none&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Lecture and clinical case discussion on CRPC<\/strong><\/span><\/h2>\n<p><!-- [et_pb_line_break_holder] --><\/p>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\">Case presenter: Daan De Maeseneer<!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Presenter: Elena Castro<!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013>Panel: Amarnath Challapalli, Rob Jones, Gero Kramer, Daniele Raggi<\/span><\/h4>\n<p><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><!-- [et_pb_line_break_holder] --><pee style=\"text-align: left;\"><span style=\"color: #ffffff;\">Presentation of a patient with mCRPC and a CDK12 mutation. The audience selects their preferred treatment option, followed by a presentation from Elena Castro in which she discusses whether PARP inhibition is the way to go in all CRPC patients. The panel discusses the impact of prior therapies and the role of different mutation types in guiding the management of these patients. Did this discussion change your opinion and that of the audience?<!-- [et_pb_line_break_holder] --><!\u2013- [et_pb_br_holder] -\u2013><\/span><\/pee><!-- [et_pb_line_break_holder] --><\/p>\n<div style=\"height:350px;position:relative;\"><iframe src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/video\/1038864698?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479&#8243;<!-- [et_pb_line_break_holder] -->frameborder=&#8221;0&#8243; allow=&#8221;autoplay; fullscreen; picture-in-picture; clipboard-write&#8221; style=&#8221;position:absolute;top:0;left:0;width:100%;height:100%;&#8221; title=&#8221;Abstract2Practice: How is clinical practice changing in advanced PCa post-ESMO?&#8221;><\/iframe><\/div>\n<p><script src=\"<!-- [et_pb_line_break_holder] -->https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_button button_url=&#8221;https:\/\/library.mirrorsmed.org\/&#8221; button_text=&#8221;Log in to watch and download RENALC, BLADDR &#038; PROSCA 2025 presentations&#8221; button_alignment=&#8221;center&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;26px&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;#006871&#8243; button_border_width=&#8221;0px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;2&#8243; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.22.1&#8243; custom_padding=&#8221;98px|||||&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.22.1&#8243; text_text_color=&#8221;#ffffff&#8221; text_font_size=&#8221;18px&#8221; header_font_size=&#8221;45px&#8221; background_layout=&#8221;dark&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: center;\"><span style=\"color: #008080;\"><strong>Clinical case discussion on Theo, 61 years old, who is diagnosed with metastatic PCa<\/strong><\/span><\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||10px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"text-align: left;\"><span style=\"color: #ffffff;\"><strong>Clinical case discussion on mHSPC<\/strong><\/span><\/h2>\n<h4 style=\"text-align: left;\"><span style=\"color: #ffffff;\">Experts: Maria De Santis, G\u00e9raldine Pignot, Gunhild von Amsberg<\/span><\/h4>\n<p style=\"text-align: left;\">\n<p style=\"text-align: left;\"><span style=\"color: #ffffff;\">The experts discuss how they would treat this patient who has low-volume PCa on conventional imaging, but high-volume disease on PSMA-PET\/CT<\/span><\/p>\n<p>[\/et_pb_text][et_pb_code _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||31px|||&#8221; custom_padding=&#8221;44px|||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"height:500px;position:relative;\"><iframe src=\"https:\/\/player.vimeo.com\/video\/1037473058?badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen style=\"position:absolute;top:0;left:0;width:100%;height:100%;\" title=\"PROSCA_2022-OFFICIAL OPENING.mp4\"><\/iframe><\/div>\n<p><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][et_pb_button button_url=&#8221;https:\/\/prosca.mirrorsmed.org\/en\/single-case\/ee6y8n64sj4ss048so4c0ws808k448g&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Which option would you suggest for this man?&#8221; button_alignment=&#8221;center&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;26px&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;#006871&#8243; button_border_width=&#8221;0px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][et_pb_text disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||17px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4 style=\"text-align: center;\">This educational activity is supported by<\/h4>\n<p><img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/library.mirrorsmed.org\/wp-content\/uploads\/2024\/12\/jnj_logo_singleline_red_rgb-300x28.png\" width=\"300\" height=\"28\" alt=\"\" class=\"wp-image-35401 aligncenter size-medium\" \/><\/p>\n<p>[\/et_pb_text][et_pb_text disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||17px|||&#8221; disabled=&#8221;on&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1><\/h1>\n<p>&nbsp;<\/p>\n<h1 style=\"text-align: center;\"><a href=\"#h_90305024211711113838082\"><strong><span style=\"color: #800080;\">Prostate cancer<\/span><\/strong><\/a><\/h1>\n<h3 style=\"text-align: center;\" id=\"h_90305024211711113838082\"><span style=\"color: #ffffff;\">Axel Merseburger<br \/>University Hospital Schleswig-Holstein, Urology<\/span><br \/><span style=\"color: #ffffff;\">L\u00fcbeck, Germany<\/span><\/h3>\n<p>[\/et_pb_text][et_pb_code disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;10px||50px|||&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"height:500px;position:relative;\"><iframe src=\"https:\/\/player.vimeo.com\/video\/907544554?h=2c46acc52a&#038;badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\" allowfullscreen style=\"position:absolute;top:0;left:0;width:100%;height:100%;\" title=\"PROSCA_2022-OFFICIAL OPENING.mp4\"><\/iframe><\/div>\n<p><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][et_pb_text disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1 style=\"text-align: center;\"><strong><span style=\"color: #800080;\">Renal cell carcinoma<\/span><\/strong><\/h1>\n<h3 style=\"text-align: center;\"><span style=\"color: #ffffff;\">Philippe Barth\u00e9l\u00e9my<\/span><br \/><span style=\"color: #ffffff;\">Strasbourg University Hospitals, Medical Oncology<br \/><\/span><span style=\"color: #ffffff; font-size: 22px;\">Strasbourg, France<\/span><\/h3>\n<p>[\/et_pb_text][et_pb_code disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-22px|||||&#8221; custom_padding=&#8221;11px|||||&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div style=\"height:500px;position:relative;\"><iframe src=\"https:\/\/player.vimeo.com\/video\/907544962?h=5c542d3d5a&#038;badge=0&#038;autopause=0&#038;player_id=0&#038;app_id=58479\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen style=\"position:absolute;top:0;left:0;width:100%;height:100%;\" title=\"PROSCA_2022-OFFICIAL OPENING.mp4\"><\/iframe><\/div>\n<p><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;19px|auto||auto||&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_button button_url=&#8221;https:\/\/ppcp.mirrorsmed.org\/en\/topic\/overview\/prostate-cancer&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;View more prostate cancer cases&#8221; button_alignment=&#8221;center&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;26px&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;#006871&#8243; button_border_width=&#8221;0px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][et_pb_button button_url=&#8221;https:\/\/ppcp.mirrorsmed.org\/en\/weekly-case-programme#subscribe&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Register to receive case challenges in your mailbox&#8221; button_alignment=&#8221;center&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;26px&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;#006871&#8243; button_border_width=&#8221;0px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#862566&#8243; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_direction=&#8221;85deg&#8221; background_color_gradient_stops=&#8221;#862566 0%|#d13f40 100%&#8221; background_color_gradient_start=&#8221;#862566&#8243; background_color_gradient_end=&#8221;#d13f40&#8243; custom_padding=&#8221;0|0px|0|0px|false|false&#8221; background_color_gradient_stops_tablet=&#8221;#862566 0%|#d13f40 100%&#8221; background_color_gradient_stops_phone=&#8221;#862566 0%|#d13f40 100%&#8221; global_module=&#8221;34636&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;89%&#8221; width_tablet=&#8221;80%&#8221; width_phone=&#8221;&#8221; width_last_edited=&#8221;on|desktop&#8221; max_width=&#8221;89%&#8221; max_width_tablet=&#8221;80%&#8221; max_width_phone=&#8221;&#8221; max_width_last_edited=&#8221;on|desktop&#8221; make_fullwidth=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text module_class=&#8221;five-columns&#8221; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-3919 alignleft size-medium\" src=\"https:\/\/library.mirrorsmed.org\/wp-content\/uploads\/2023\/09\/MiMe_white-300x83-1.png\" alt=\"Mirrors of Medicine\" width=\"150\" height=\"83\" \/><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text module_class=&#8221;five-columns&#8221; _builder_version=&#8221;4.22.1&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span style=\"color: #ffffff;\">Part of<\/span><br \/><strong><span style=\"color: #ffffff;\">ISSECAM<\/span><\/strong><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text module_class=&#8221;five-columns&#8221; _builder_version=&#8221;4.22.1&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span style=\"color: #ffffff;\">Contact us<\/span><br \/><a href=\"mailto:info@mirrorsofmedicine.org\"><strong><span style=\"color: #ffffff;\">info@mirrorsofmedicine.org<\/span><\/strong><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_social_media_follow module_class=&#8221;five-columns&#8221; _builder_version=&#8221;4.22.1&#8243; text_orientation=&#8221;right&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_social_media_follow_network social_network=&#8221;twitter&#8221; url=&#8221;https:\/\/twitter.com\/mirrorsmed&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#00aced&#8221; filter_saturate=&#8221;0%&#8221; global_colors_info=&#8221;{}&#8221; follow_button=&#8221;off&#8221; url_new_window=&#8221;on&#8221;]twitter[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=&#8221;linkedin&#8221; url=&#8221;https:\/\/www.linkedin.com\/company\/issecam\/&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#007bb6&#8243; filter_saturate=&#8221;0%&#8221; filter_brightness=&#8221;140%&#8221; global_colors_info=&#8221;{}&#8221; follow_button=&#8221;off&#8221; url_new_window=&#8221;on&#8221;]linkedin[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=&#8221;youtube&#8221; url=&#8221;https:\/\/www.youtube.com\/channel\/UCL871UYXCR6vBsj8NPoUmHA&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#a82400&#8243; filter_saturate=&#8221;0%&#8221; filter_brightness=&#8221;200%&#8221; global_colors_info=&#8221;{}&#8221; follow_button=&#8221;off&#8221; url_new_window=&#8221;on&#8221;]youtube[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mirrors of Medicine libraryIn the spotlightHow to approach an mHSPC patient: Insights from clinical practicePresentor: Amit Bahl Tailor mHSPC treatment by counseling patients on all treatment options, proactively managing adverse events to optimize outcomes\/quality of life, and leveraging multidisciplinary care.<\/p>\n","protected":false},"author":11,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"_links":{"self":[{"href":"https:\/\/library.mirrorsmed.org\/index.php\/wp-json\/wp\/v2\/pages\/36032"}],"collection":[{"href":"https:\/\/library.mirrorsmed.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/library.mirrorsmed.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/library.mirrorsmed.org\/index.php\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/library.mirrorsmed.org\/index.php\/wp-json\/wp\/v2\/comments?post=36032"}],"version-history":[{"count":29,"href":"https:\/\/library.mirrorsmed.org\/index.php\/wp-json\/wp\/v2\/pages\/36032\/revisions"}],"predecessor-version":[{"id":36094,"href":"https:\/\/library.mirrorsmed.org\/index.php\/wp-json\/wp\/v2\/pages\/36032\/revisions\/36094"}],"wp:attachment":[{"href":"https:\/\/library.mirrorsmed.org\/index.php\/wp-json\/wp\/v2\/media?parent=36032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}